A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.
StockStory.org on MSN
3 mid-cap stocks that concern us
Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...
PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
Morning Overview on MSN
Scientists traced why H5N1 bird flu hits cows’ udders instead of their lungs
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
After several examples of undisclosed alterations in reagent suppliers’ antibody catalogues surfaced, researchers call for transparency to rebuild trust.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results